The global Healthcare Specialty Enzymes Market was valued at USD 1.86 billion in 2022, and it is projected to reach USD 3.5 billion by 2032, with a CAGR of 7.2% during the forecast period. The growing prevalence of chronic diseases and the increasing demand for personalized treatment are the primary factors driving market growth. Specialty enzymes find applications in various industries, including biotechnology, pharmaceuticals, research and diagnostics, food and drinks, textiles, detergents, paper and pulp, and animal feed.
In the pharmaceutical industry, enzymes are used to produce biologics, which are increasingly being used to treat chronic illnesses such as cancer, autoimmune diseases, and rare genetic diseases. Biologics are complex compounds produced by living cells that require specialized enzyme production.
Get a free sample PDF of the report, visit @
https://www.reportsanddata.com/download-free-sample/6369
The market is also being driven by the increasing demand for personalized treatment. Personalized medicine is a new approach to healthcare that develops treatment regimens for each patient based on their specific genetic makeup, lifestyle, and environmental circumstances. Enzymes play a crucial role in the development of personalized medicine, as they are used to create biologics tailored to an individual's unique needs.
Key players in the Healthcare Specialty Enzymes Market:
- Abbott Laboratories
- BASF SE
- Bristol-Myers Squibb Company
- Danisco A/S
- DSM N.V.
- E. I. du Pont de Nemours and Company
- Johnson Johnson
- Lonza Group AG
- Neutrogena Corporation
- Novo Nordisk A/S
- Roche Holding AG
Furthermore, the use of enzyme-based therapeutics is also expected to drive market revenue growth. Enzyme Replacement Therapy (ERT) is used to replace missing or ineffective enzymes in individuals with genetic diseases. ERT has successfully treated many genetic disorders, including Gaucher disease, Fabry disease, and Pompe disease, among others.
RD expenditures and the development of new specialty enzymes are other factors driving market revenue growth. Industry players are investing heavily in RD to create new specialty enzymes that can be used in various ways. For instance, in June 2021, Novozymes launched a new enzyme solution for the animal feed sector, which is intended to assist chicken farmers in increasing protein digestibility and lowering feed costs.
However, new entrants face barriers to entry due to the technical and specialized nature of the industry, the focus on RD, and the scarcity of skilled professionals.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6369
The North America market is expected to dominate the healthcare specialty enzymes market due to the presence of a large number of biopharmaceutical companies in the region. Specialty enzymes are used for various applications such as drug development, tissue engineering, food processing/flavoring, and bioprocessing.
In terms of type, the healthcare specialized enzymes market is segmented into protease, lipase, carbohydrase, and others. The protease segment accounted for the largest revenue share in the global healthcare specialty enzymes market in 2022. The lipase enzymes segment is expected to register a moderately fast revenue growth rate during the forecast period due to the ability of lipase enzymes to break down fats into glycerol and fatty acids, which is crucial for treating various digestive disorders. The carbohydrase enzymes segment is expected to account for a significantly large revenue share in the global healthcare specialty enzymes market during the forecast period due to the rising demand for carbohydrase enzymes in the healthcare sector.
Government regulations are in place to regulate the use of enzymes in the production of pharmaceuticals, biologics, and nutraceuticals. For example, the US Food and Drug Administration (FDA) regulates enzymes used in the manufacture of pharmaceuticals, biologics, and nutraceuticals. The US Department of Agriculture (USDA) sets standards for enzymes used in food manufacturing processes, while the Occupational Safety and Health Administration (OSHA) sets safety regulations for enzyme handling in the workplace. The European Union (EU) regulates enzymes used in food manufacturing processes through its Novel Food Regulation (EC) No 258/97. The Canadian Food Inspection Agency (CFIA) sets standards for enzymes used in food processing and manufacturing processes.
Request customization of the report @
https://www.reportsanddata.com/request-customization-form/6369
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse for more reports:
